The Role of HMGB-1 in Chronic Stroke

Description

The purpose of this study is to measure the presence of HMGB-1 and other proteins in the blood across five time points after stroke, and to determine if their presence correlates with rate of stroke recovery.

Study Start Date

September 2012

Estimated Completion Date

August 2016

Interventions

No interventions cited

Specialties

  • Internal Medicine: Neurology
  • Neurology: Stroke/Vascular

MeSH Terms

  • Cerebral Infarction
  • Stroke

Study ID

North Shore Long Island Jewish Health System -- 12-090B

Status

Unknown

Trial ID

NCT01705353

Study Type

Observational

Trial Phase

N/A

Enrollment Quota

100

Sponsor

North Shore Long Island Jewish Health System

Inclusion Criteria

  • Patients admitted to the stroke service at Northshore and LIJ Medical Centers
  • Patients 18 years of age or older

Exclusion Criteria

  • Patients < 18 years of age

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
North Shore University Hospital - Manhasset, New York 37.0 miles None None None
Long Island Jewish Medical Center - New Hyde Park, New York 39.6 miles None None None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.